Go to deals
Consumer & Retail | Healthcare

Periproducts Limited has been acquired by Venture Life Group plc

The private shareholders of Periproducts Limited have sold the company to Venture Life Group plc for US$8 million.

Perirpoducts is an independent, privately owned British company that produces and markets the award-winning UltraDEX Performance Oral Care range. Over the last 20 years, the company has been recognized for its innovative oral care products, incorporating the latest ingredients and technology, and backed by scientific research.

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercializing products for the ageing population. The group’s product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

Oaklins Cavendish, based in the UK, advised the seller in this transaction.

Parties

Talk to the deal team

Peter Gray

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

Kaviari has received a minority investment from idiCo
Consumer & Retail

Kaviari has received a minority investment from idiCo

Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.

Learn more
AWC has acquired a significant minority stake in MyFitness
Consumer & Retail

AWC has acquired a significant minority stake in MyFitness

AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more